Literature DB >> 23801903

Exercise guidelines for inpatients following ventricular assist device placement: a systematic review of the literature.

Rachel Scheiderer1, Courtney Belden, Darla Schwab, Casey Haney, Jaime Paz.   

Abstract

BACKGROUND: For patients with end-stage heart failure awaiting transplantation, lack of donor organs has created an increased need for alternatives such as left ventricular assist device (LVAD) implantation. The purpose of this study is to determine safe and effective exercise parameters for physical therapy in the acute care setting.
METHODS: A systematic literature review was conducted according to PRISMA guidelines using Sackett's Levels of Evidence to rate the evidence. Multiple databases were searched with inclusion criteria of: available in English, inpatient care up to 6 months postoperatively, description of intervention type and exercise parameters. EXCLUSION CRITERIA: no defined exercise parameters, outpatient treatment, infection post VAD, or palliative or hospice care post VAD.
RESULTS: Six studies out of 1,291 articles met inclusion criteria. Common exercise parameters used were the Borg Rating of Perceived Exertion scale 11-13 (6-20 scale) or > 4 (0-10 scale), Dyspnea scale > 2 (0-4 scale) and > 5 (0-10 scale), mean arterial pressure (MAP) 70-95 mmHg, and LVAD flow > 3L/min. Levels of evidence ranged from case controlled to expert opinion.
CONCLUSION: Current evidence on inpatient exercise parameters for patient's status post LVAD implantation is not sufficient to suggest definitive guidelines; however, these exercise parameters provide a reference for patient care.

Entities:  

Keywords:  exercise; physical therapy; ventricular assist device

Year:  2013        PMID: 23801903      PMCID: PMC3691707     

Source DB:  PubMed          Journal:  Cardiopulm Phys Ther J        ISSN: 1541-7891


  23 in total

1.  Bridge to life--cardiac mechanical support.

Authors:  Kenneth L Baughman; John A Jarcho
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

Review 2.  Aerobic exercise training intensity in patients with chronic heart failure: principles of assessment and prescription.

Authors:  Vitor Oliveira Carvalho; Alessandro Mezzani
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2011-02

3.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

4.  Mechanical circulatory support as a bridge to transplant candidacy.

Authors:  Abdelsalam M Elhenawy; Khaled D Algarni; Marnie Rodger; Jane Maciver; Manjula Maganti; Robert J Cusimano; Terrence M Yau; Diego H Delgado; Heather J Ross; Vivek Rao
Journal:  J Card Surg       Date:  2011-08-28       Impact factor: 1.620

5.  Total artificial heart and physical therapy management.

Authors:  Clare Nicholson; Jaime C Paz
Journal:  Cardiopulm Phys Ther J       Date:  2010-06

6.  Exercise blood pressure response during assisted circulatory support: comparison of the total artificial [corrected] heart with a left ventricular assist device during rehabilitation.

Authors:  Harajeshwar S Kohli; Justin Canada; Ross Arena; Daniel G Tang; Mary Ann Peberdy; Suzanne Harton; Maureen Flattery; Kelly Doolin; Gundars J Katlaps; Michael L Hess; Vigneshwar Kasirajan; Keyur B Shah
Journal:  J Heart Lung Transplant       Date:  2011-08-20       Impact factor: 10.247

Review 7.  Left ventricular assist device-related infections: past, present and future.

Authors:  Sanjay Maniar; Sreekanth Kondareddy; Veli K Topkara
Journal:  Expert Rev Med Devices       Date:  2011-09       Impact factor: 3.166

8.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

9.  Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.

Authors:  Jeremiah G Allen; Eric S Weiss; Justin M Schaffer; Nishant D Patel; Susan L Ullrich; Stuart D Russell; Ashish S Shah; John V Conte
Journal:  J Heart Lung Transplant       Date:  2009-10-17       Impact factor: 10.247

10.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

View more
  4 in total

Review 1.  Approaches to improving exercise capacity in patients with left ventricular assist devices: an area requiring further investigation.

Authors:  Richard Severin; Ahmad Sabbahi; Cemal Ozemek; Shane Phillips; Ross Arena
Journal:  Expert Rev Med Devices       Date:  2019-09-06       Impact factor: 3.166

2.  Isolated left ventricular assist device implantation produces variable changes to patient body mass index.

Authors:  Sonal R Chandratre; Nathan J Smith; Richard W Walsh; Tammy L Kindel; Sakthi K Sundararajan; David L Joyce; Asim Mohammed
Journal:  Artif Organs       Date:  2022-03-17       Impact factor: 2.663

3.  Exercise Performance During the First Two Years After Left Ventricular Assist Device Implantation.

Authors:  Christiane Marko; Endri Xhelili; Thomas Lackner; Daniel Zimpfer; Heinrich Schima; Francesco Moscato
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

4.  Exercise gas exchange in continuous-flow left ventricular assist device recipients.

Authors:  Alessandro Mezzani; Massimo Pistono; Piergiuseppe Agostoni; Andrea Giordano; Marco Gnemmi; Alessandro Imparato; Pierluigi Temporelli; Ugo Corrà
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.